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Bovine heart submitochondrial particles were treated with a medium containing Triton X- 114 and cardio- 
lipin. The extract was subjected to hydroxyapatite chromatography. Only a few major polypeptides of simi- 
lar molecular masses were found in the eluate, as shown by electrophoresis n an SDS-polyacrylamide gel 
stained with silver. The eluate was reconstituted into liposomes and was shown to catalyse two different 
transport activities: 2-oxoglu~rate-2-oxo~u~rate exchange sensitive to phthalonate and phenylsu~inate 
and pyruvate-py~vate xchange sensitive to 2-cyano-~hydroxycinn~ate. Since both activities were found 
to have characteristics simiIar to those described for intact mitochondria, it was concluded that at least two 
of the polypeptides found in the hydroxyapatite luate correspond to the two mitochondrial carriers. 
Mitochondria Anion transport 2-Oxoglutarate carrier Monocarboxylate carrier Pyruvate transport 
Reconstitution 
1. INTRODUCTION 
The transport of substrate anions across the in- 
ner mitochondrial membrane is catalysed by 
specific carrier proteins. Their existence and 
specificity were first demonstrated by the observa- 
tion that mit~hondria swell when suspended in 
solutions of certain substrates and subsequently by 
studying the accumulation of the radioactive 
substrates (review see [l]). It is now established 
that the inner mitochondrial membrane contains at 
least 12 functionally different carriers [ 1,2]. Recent 
studies were focused on the molecular mechanism 
of the transport together with the isolation of the 
Abbreviations: HTP, hydroxyapatite; Mops, 3-(N- Here we report the identification of 2 other 
morpholino)propanesulfonic acid; PPO, l,Cdi+phen- mitochondrial carriers present in the HTP eluate, 
yloxazolyl)benzene; POPOP, 2,5-diphenyloxazole the 2-oxoglutarate and pyruvate transporters. 
carrier proteins. Some of the mitochondrial car- 
riers have already been isolated in a pure form, e.g. 
the ATP-ADP translocator [3,4] and the 
phosphate carrier [5-71; some others have been ex- 
tracted and partially purified and their activity has 
been measured after reconstitution into liposomes, 
e.g. the tricarboxylate carrier [8,9], dicarboxylate 
carrier {lO,Il], glutamate carrier [12] and 
glutamate-aspartate xchanger [13]. It is in- 
teresting to note that most of the purification pro- 
cedures used hydroxyapatite (HTP) chromatog- 
raphy as an important step, suggesting structural 
similarities between the different transport pro- 
teins. A possible explanation of the efficiency of 
hydroxyapatite in the puri~cation of hydrophobic 
proteins has been proposed [ 141. 
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2. MATERIALS AND METHODS 
2.1. Materials 
Beef heart mitochondria were prepared by a 
standard procedure [15]. Submitochondrial par- 
ticles were obtained by sonication of mitochondria 
and subsequent differential centrifugation [ 16f. 
Triton X-114, EDTA and phenylsuccinate were 
from Fiuka. Mops, folin reagent, PPO, POPOP 
and substrates were from Merck. The radioactive 
substrates (2-oxo[l-14C]glutaric acid, sodium salt 
and [l-‘4C]pyruvic acid, sodium salt) were from 
Amersham; asolectin (extract of phospholipids 
from soy beans) from Associated Concentrates; 
cardiolipin (solution 5 mglml in ethanol) and 
2-cyano-4-hydroxycinnamate from Sigma; hydrox- 
yapatite (HTP-biogel, dry powder) and Dowex AG 
l-X& Cl- form, 200-400 mesh were from BioRad. 
Phthalonate was a generous gift from Dr A. J. Mei- 
jer, University of Amsterdam. All other chemicals 
were of analytical grade. 
Buffer A for solubilization of the membranes 
and hydroxyapatite chromatography: 4% Triton 
X-114, 50 mM NaCl, 1 mM EDTA, 20 mM Mops 
and cardiolipin (2 mg/ml), final pH 7.2. This solu- 
tion was always freshly prepared by sonicating 
(with cooling and under nitrogen) for about 
10 min, until clear. 
Buffer B enclosed in liposomes: 50 mM NaCl, 
10 mM Mops and 10 mM 2-oxoglutarate or 
pyruvate (final pH 7.2). 
Buffer C for transport measurements: 100 mM 
NaCl, 20 mM Mops (final pH 7.2) and either 
2 mM radioactive 2-oxoglutarate (final spec. act. 
about 0.8 mCi/mol) or 5 mM radioactive pyruvate 
(final spec. act. about 0.4 mCi/mol). The exact 
specific radioactivity of buffer C was always 
measured before the experiment. 
Scintillation cocktail: 7 g PPO and 300 mg 
POPOP were dissolved in 1 1 toluene. 700 ml of 
this solution was mixed with 300 ml of absolute 
ethanol and used as the scintillation cocktail. 
2.2. Solubilization 
A 0.5 ml sample of freshly thawed sub- 
mitochondrj~ particles (approx. 15 mg protein) 
was mixed with 1.2 ml buffer A and gently 
homogenized. The suspension was kept in ice for 
20 min and then centrifuged at 100000 x g for 
40 min. The brown-red pellet was discarded and 
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the yellowish solubilizate was either reconstituted 
directly or subjected to hydroxyapatite 
chromatography. 
2.3. HTP-chromatography 
600 mg dry-HTP gel was placed in a small 
disposable plastic column and cooled for 15 min at 
- 20°C. The column was loaded with 0.6 ml of the 
supernatant obtained from the previous step and 
eluted with an additional 1.8 ml buffer A. The col- 
lected eluate (about 0.5 ml) was subsequently used 
for reconstitution, protein determination and gel 
electrophoresis. 
2.4. Reconstitution 
Liposomes were made from asolectin by first 
swelling of the dry lipid in buffer B (125 mg asolec- 
tin/ml buffer) for 2 h in the cold and then 
sonicating the suspension until clear (approx. 
10 mm, 50% duty), with cooling and under 
nitrogen. The liposomes obtained were divided in- 
to 360~1 samples and kept in ice. Reconstitution 
was started by addition of 20 ~1 of either extracted 
membranes (supernatant after solubilization) or 
HTP eluate to a sample of liposomes. The samples 
were mixed, allowed to stand in ice for 2 min, then 
quickly frozen in liquid nitrogen followed by slow 
thawing at room temperature. When thawed, each 
sample was sonicated with a microtip (5OYo duty, 
in the cold under nitrogens until clear and subse- 
quently passed through a small column of Dowex 
to remove the external substrate. The resin was 
previously equilibrated with 170 mM sucrose. 
2.5. Transport (2-oxoglutarate-2-oxoglutarate or 
pyruvate-pyruvate xchange) 
300 ~1 aliquots of proteoliposomes were used per 
assay. 
2.5.1. For 2-oxoglutarate 
The control samples were supplemented with 
20~1 of 100 mM phenylsuccinate or 1041 of 
100 mM phthalonate to inhibit the exchange activi- 
ty and subsequently with 30~1 radioactive 
substrate solution (buffer C) to give the final exter- 
nal Z-oxoglutarate concentration of 0.2 mM. The 
assay samples were supplemented first with the 
substrate (30 pl buffer C) and only after a certain 
time were inhibited as above. ‘Zero-time’ samples 
were supplemented with a mixture of inhibitor and 
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substrate solutions and were immediately pro- 
cessed further, i.e. quickly passed through a small 
column of Dowex, to remove external, not ex- 
changed radioactive 2-oxoglutarate. The exchange 
reaction was measured at 20°C. 
2.5.2. For pyruvate 
Samples were preincubated for 3 min with or 
without 1 mM 2-cyano-4-hydroxycinnamate [17]. 
The exchange reaction was started by addition of 
substrate (buffer C). The final concentration of 
pyruvate was 0.5 mM. The incubation was per- 
formed at WC and the reaction was stopped by 
passing the mixture through a Dowex column. Ali- 
quots of the eluate were pipetted into scintillation 
vials, mixed with the scintillation cocktail and 
counted for radioactivity. 
2.6. Protein determination 
The procedure of Lowry et al. 1181 was modified 
by the addition of SDS (final concentration 5%) to 
avoid turbidity problems due to the presence of 
lipid and high concentrations of Triton X-114. 
Bovine serum albumin was used as a protein stan- 
dard and the standard curve was prepared in the 
presence of both Triton, buffer A and SDS. 
2.7. Poiy~cry~a~~de-S~S gel e~ectro~horesis 
The electrophoresis was performed according to 
Laemmli 1191 by using a 17.5% polyacrylamide 
separation gel as described in [20]. Before loading 
the Triton extract samples were incubated with 4% 
SDS. The HTP-eluate samples were supplemented 
with SDS to a concentration of 1% and subse- 
quently extracted with 2 vols chloroform. The 
aqueous phases were concentrated by ultrafiltra- 
tion in Minicon B15. The following molecular 
mass marker proteins were used: phosphorylase b 
(94 kDa), BSA (67 kDa), carbonic anhydrase 
(30 kDa) and cytochrome c (12 kDa). All samples 
contained 2-mercaptoethanol. 
3. RESULTS AND DISCUSSION 
3.1. Z-Oxog~utarate carrier 
The procedure used for the extraction of the 
native 2-oxoglutarate transporter from bovine 
heart submitochondrial particles consisted of 2 
main steps. First, submitochondrial particles were 
treated with Triton X-114 in the presence of car- 
diolipin (2 mg/ml). Second, the extracted material 
was passed through hydroxyapatite. Fig.1 shows 
the polypeptide patterns obtained after SDS- 
polyacrylamide electrophoresis of the Triton ex- 
tract and the HTP eluate. The comparison of the 
silver-stained polypeptides in both fractions 
demonstrated a considerable purification by a 
single HTP-chromatography step. Many bands are 
visible in the extracted fraction whereas only a few 
bands can be distinguished in the HTP eluate. 
They are mainly located in the 30-37 kDa region. 
Table 1 describes the results of the purification 
procedure. Only 1% of the total membrane pro- 
teins are recovered in the HTP eluate. On the other 
hand, the specific transport activity is increased 
more than about 150-fold. The exact purification 
factor is difficult to estimate due to 2 problems, 
namely that the measured activity is dependent on 
the efficiency of reconstitution and that in- 
A B C 
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Fig. 1. Poiypeptide composition of the Triton extract and 
HTP eluate. SDS gel electrophoresis was performed in a 
17.5% polyacrylamide separation gel as described in 
section 2. The polypeptides were fixed with 
formaldehyde and stained by the silver nitrate method. 
About 25 /cg of the Triton extract (A), 10 pg of the HTP 
eluate (B) and 0.3pg of each marker protein (C) were 
loaded. 
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Table 1 
February 1986 
Purification of the 2-oxoglutarate carrier from bovine heart submitochondrial particles 
Fraction Protein 
yield 
(mg) (Tao) 
Phenylsuccinate- 
sensitive 
2-oxoglutarate uptake 
Total Specific 
activity activity 
(nmol/min) (nmol/min 
per mg) 
Purification 
(-fold) 
Triton X- 114 
extract of SMP 13.70 39.3 7.2 0.53 1 
HTP eluate 0.36 1.0 29.6 82.11 155 
Frozen submitochondri~ particles (35 mg protein) were used as starting material. Both fractions (Triton 
extract and HTP eluate) were reconstituted and the exchange reactions were measured for 1 min as 
described in section 2. Only the phenylsuccinate-sensitive activity is presented. The data represent mean 
values from 5 separate experiments 
complete solubilization of the carrier protein and 
its possible partial denaturation by the detergent 
can occur. A similar point was considered recently 
in the case of the isolation of the dicarboxylate car- 
rier from mitochondria [ 11 f. 
Fig.2 shows the time course of the 
phenylsuccinate-sensitive uptake of external 
2-oxo[ 1 -r4C]glutaric acid in exchange for internal 
Fig.2. Time dependence of phenylsuccinate-sensitive 
2-oxo[l-14C]glutarate uptake during 2-oxoglutarate-2- 
oxoglutarate exchange in reconstituted proteoliposomes 
prepared from the HTP eluate. Procedures of re- 
constitution and transport measurements are described 
in section 2. All points represent mean values of activity 
calculated from 3 separate xperiments. 
2-oxoglutarate. Fig.2 indicates that the uptake pro- 
ceeds linearly for about 1 min and then reaches a 
plateau at about 82 nmol oxoglutarate/mg pro- 
tein. The presence of radioactivity in the zero-time 
sample is due to penetratjon of substrate into the 
liposomes during the time necessary to pass the 
sample through Dowex and/or radioactive ox- 
oglutarate which is binding to the liposomes. 
Table 2 summarizes the inhibitor sensitivity and 
substrate specificity of the reconstituted ox- 
oglutarate exchanger. The data indicate that both 
phthalonate and phenylsuccinate are potent in- 
hibitors of the carrier. Furthermore, dicarbox- 
ylates such as malate, malonate and oxaloacetate 
substantially lower oxogiutarate uptake, whereas 
glutamate and citrate do not compete. The finding 
that malate is a more effective inhibitor than 
malonate and oxaloacetate is in agreement with the 
observation that the iu, for malate in intact 
mitochondria is much lower than the values for the 
other acids [l]. 
All this led us to the conclusion that the ox- 
oglutarate exchanging activity found in the HTP 
eluate is identical to the mitochondrial 
2-oxoglutarate transport activity. 
3.2. Pyruvate (monocarboxylate) carrier 
The Triton extract of mitochondria and its fur- 
ther purification products employed in the study of 
the 2-oxoglutarate transporter were also checked 
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Table 2 
The effect of inhibitors and the substrate specificity of the partially purified, r~onstituted 
Z-oxoglutarate xchanger 
Addition 
(mM, final) 
2-Oxoglutarate accumulation 
(uncorrecteda) 
(nmol/min per @Jo) 
mg protein) 
Net uptake of radioactive 
2-oxoglutarate 
(correcteda) 
(nmol/min per (070 inhibition) 
mg protein) 
None 114.2 100 84.8 
2.9 mM phthalonate 29.4 26 0.0 100 
5.7 mM phenylsuccinate 30.8 27 1.4 98 
28.6 mM malate 41.1 36 11.7 86 
28.6 mM malonate 50.3 44 20.9 75 
28.6 mM oxaloacetate 44.5 39 15.1 82 
28.6 mM glutamate 116.5 102 87.1 none 
28.6 mM citrate 111.9 98 82.5 3 
a The corrected values are obtained by subtracting the phthalonate-insensitive accumulation of 
2-oxoghttarate 
The HTP eluted carriers were reconstituted and the 2-oxogiutarate-2-oxoglut~ate exchange activity 
was measured as described in section 2. The values of activity represent he total accumulation of 
radioactive 2-oxoglutarate, not corrected for the inhibitor sensitivity and the net uptake of 
2-oxoghrtarate, corrected for phthalonate-insensitive accumulation. The data are mean values from 
2 separate experiments. The listed anions were adjusted to about pH 7.2 (except for phth~onate 
and oxaloacetate which were adjusted to about 6.7) and were added externally. The samples were 
preincubated for 1 min prior to the addition of the radioactive 2-oxoglutarate. The temperature was 
20°C and the time of incubation was 2 min. The reaction was stopped by quickly passing the 
mixture through a Dowex column 
for the possible presence of the pyruvate 
(monocarboxylate) carrier. This protein has been 
reported to catalyse 2 reactions in mitochondria, 
the Ap~dependent uptake of monocarboxylates 
and their exchange. Since it is difficult to maintain 
and control a stable ApH across a liposomal mem- 
brane, the exchange reaction has been chosen as a 
standard assay for the monocarboxylate carrier ac- 
tivity. Only the 2-cyano-4-hydroxycinn~ate- 
sensitive reaction was considered specific in the ac- 
tivity calculations. The mechanism of inhibition of 
the pyruvate transporter by cinnamate derivatives, 
possibly involving a covalent binding to -SH 
groups, has been a matter of debate (review see 
[21]). It was proposed by Halestrap et al. [21] that 
cinnamate derivatives bind on the inner side of the 
inner mitochondrial membrane, this being a possi- 
ble reason for the need of a preincubation time 
when using these inhibitors. 
Here it was found that both the Triton extract of 
the inner mitochondrial membrane and the HTP 
eluate, after reconstitution into liposomes, were 
able to catalyse an active, 2-cyano~-hydroxycin- 
namate-sensitive xchange of pyruvate. Table 3 
summarizes the results of the purification pro- 
cedure. The calculated purification factor for the 
HTP chromatography amounted to about 7%fold, 
i.e. was considerably lower than in the case of the 
oxoglutarate carrier (see table 1). Such a result may 
be a consequence of inaccurate insertion of the car- 
rier into the liposome membrane or of an inactiva- 
tion during the purification procedure, An even 
lower purification factor was recently reported for 
the aspartate/glutamate exchanger using a similar 
procedure [13]. The purification procedure for the 
monocarboxylate carrier might be improved by 
using different phospholipids, detergents and salts. 
The reconstituted pyruvate carrier was found to 
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Table 3 
February 1986 
Purification of the monocarboxylate carrier from bovine heart submitochondrial particles 
Fraction Protein yield 
(mg) (Q) 
Pyruvate exchange 
Total Specific 
activity activity 
(nmol/min) (nmol/min per mg) 
Purification 
(-fold) 
Triton X-1 14 
extract of SMP 
HTP eluate 
13.70 39.3 60.2 4.4 1 
0.36 1.0 119.2 331.0 75 
Frozen submitochondrial particles (35 mg protein) were used as starting material. Proteins from both 
fractions (Triton extract and HTP eluate) were reconstituted and the exchange reactions were measured 
for 2 min as described in section 2. Only the 2-cyano-4-hydroxycinnamate-sensitive pyruvate exchange is 
shown. It represents 50-70% of the total pyruvate accumulation. The data represent mean values from 
3 separate experiments 
be specific for monovalent keto acids and not in- 
fluenced by dicarboxylates and tricarboxylates and 
its inhibitor sensitivity (not shown) was similar to 
what has been described for mitochondria. These 
2 findings suggest that, under the conditions 
described, together with other carriers also the 
mitochondrial monocarboxylate transporter is co- 
purified. 
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